NDC 50090-4503

Victoza

Liraglutide

Victoza is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Liraglutide.

• Product ID: 50090-4503_67e5abcc-e7f9-4a6a-85b6-70a94049e250
• NDC: 50090-4503
• Product Type: Human Prescription Drug
• Proprietary Name: Victoza
• Generic Name: Liraglutide
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2010-01-25
• Marketing Category: NDA / NDA
• Application Number: NDA022341
• Labeler Name: A-S Medication Solutions
• Substance Name: LIRAGLUTIDE
• Active Ingredient Strength: 6 mg/mL
• Pharm Classes: GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 50090-4503-0

3 SYRINGE, PLASTIC in 1 CARTON (50090-4503-0) > 3 mL in 1 SYRINGE, PLASTIC

• Marketing Start Date: 2019-09-04
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 50090-4503-0 [50090450300]

Victoza INJECTION

• Marketing Category: NDA
• Application Number: NDA022341
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-09-04

Drug Details

Active Ingredients

Ingredient	Strength
LIRAGLUTIDE	6 mg/mL

OpenFDA Data

• SPL SET ID: 35e613e3-7aae-4152-b827-99d1ee7841be
• Manufacturer:
  • A-S Medication Solutions
• UNII:
  • 839I73S42A
• RxNorm Concept Unique ID - RxCUI:
  • 897122
  • 897126

Pharmacological Class

• GLP-1 Receptor Agonist [EPC]
• Glucagon-Like Peptide 1 [CS]
• Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
• GLP-1 Receptor Agonist [EPC]
• Glucagon-Like Peptide 1 [CS]
• Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

NDC Crossover Matching brand name "Victoza" or generic name "Liraglutide"

NDC	Brand Name	Generic Name
0169-4060	Victoza	liraglutide
50090-2853	Victoza	liraglutide
50090-4503	Victoza	liraglutide
0169-2800	Saxenda	liraglutide
50090-4257	Saxenda	liraglutide